Commercial Deployment of Integrated PAT Technologies to Enable Continuous Upstream Production of Glycosylated Monoclonal Antibodies
Obtaining extensive in- and at-line input and output analytics combined with machine learning to improve predictive CQA
An Integrated Platform for Fully Automated, Continuous, & Real-Time Multi-Attributes Monitoring of Upstream Processes for Glycosylated Monoclonal Antibodies Production
Continuous Countercurrent Spiral Chromatography (CCSC) – Feasibility, Demonstration and Commercialization
At-Bioreactor Trace Metal Quantification and Statistical Process Control in CHO Cell-culture Production